What does CEFALY do?
CEFALY relieves migraine pain and reduces the frequency of migraine attacks.
Most migraine attacks involve the trigeminal nerve, the largest and most complex cranial nerve. CEFALY is an external trigeminal nerve stimulation (eTNS) device. It sends tiny electrical impulses through a self-adhesive electrode placed on the forehead to stimulate the trigeminal nerve.
One device. Two settings.
ACUTE Treatment
Use this 60-minute program at the earliest sign of a migraine attack to relieve pain and other symptoms.
PREVENT Treatment
Use this 20-minute program every day to raise your trigger threshold and reduce migraine days.
How to use CEFALY
1. PREP
Clean and dry your forehead, then apply the electrode.
2. RELAX
Lie back and attach your CEFALY device. Optional: Pair CEFALY Connected with the CeCe app to control and track treatments with your phone.
3. SELECT
Choose ACUTE for rapid migraine relief, or PREVENT for daily migraine prevention.
4. TREAT
Adjust the stimulation so it's comfortable.
What does CEFALY feel like?
CEFALY treatment feels like a gentle tingling or vibrating. The sensation might feel a little strange at first, but most people get used to it after a few sessions.
You have full control of the stimulation intensity. When starting an ACUTE or PREVENT treatment session, the stimulation gradually increases. At any time during the first 14 minutes of a session, press the device button once or use the CeCe app to stabilize the intensity at the level you prefer. It should be both comfortable and noticeable.
Why CEFALY?
No drugs, surgery, or injections
CEFALY is a drug-free, non-invasive medical device that treats and prevents migraine. See our clinical studies.
Treat anytime, anywhere
CEFALY’s compact design and long battery life make it easy to take on the go.
Easy to use
Control your CEFALY with the single device button or the CeCe app (Connected only) with built-in migraine tracking.
Safe and well tolerated
Recommended by leading headache specialists and neurologists.
- [1]: Chou DE, Shnayderman Yugrakh M, Winegarner D, Rowe V, Kuruvilla D, Schoenen J. Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial. Cephalalgia. 2018;39(1):3-14.
- [2]: Kuruvilla DE, Mann JI, Tepper SJ, Starling AJ, Panza G, Johnson MAL. Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM). Scientific Reports. 2022;12(1):5110.
- [3]: Schoenen J, Vandersmissen B, Jeangette S. Migraine prevention with a supraorbital transcutaneous stimulator: A randomized controlled trial. Published online in Neurology, 2013.